Oncology & Cancer

Researchers discover why new melanoma drug stops working

(Medical Xpress) -- Research led by investigators at Memorial Sloan-Kettering Cancer Center has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib, an oral targeted therapy ...

page 16 from 40